A study of the susceptibility to cefotaxime and six other cephalosporins in 213 nonselected strains of nine different bacterial species clearly showed that cefotaxime was the most active against aerobic gram-negative bacilli. The same pattern emerged with 84 cephalothin-resistant strains of five enterobacterial species, but the mean minimal inhibitory concentration values for all cephalosporins were about twofold higher in this group of strains. Cephalothin was the most active antibiotic against Staphylococcus aureus. The inoculum effect of 10 cephalothinresistant strains was relatively small, but it was most marked for cefamandole, as compared with that of three other niew cephalosporins, including cefotaxime. The susceptibility of these cephalosporins to beta-lactamases from 12 beta-lactamaseproducing enterobacterial strains was determined. Half of these were slightly active against cefotaxiine and had imilar activity against cefuroxime. Cefoxitin was not degraded at all, and cefamandole was the most susceptible. No correlation between beta-lactamase susceptibility and minimal inhibitory concentration values of different cephalosporins was found. Cefotaxime combined high intrinsic antibiotic activity with marked resistance to beta-lactamase inactivation.
Several new cephalosporins became available and have been investigated in the last few years. Among these are cefamandole, which has high intrinsic antibacterial activity (2, 3), cefuroxime, which appears to be more active than cephalothin and shows resistance to inactivation by beta-lactamases (5, 9) , and cefoxitin, which combines a high degree of beta-lactamase resistance with activity against many anaerobes (10, 13) . The new cephalosporin, cefotaxime (HR 756), has been studied in vitro (1, 6, 7, 12) and appears to be promising in view of its low minimal inhibitory concentration (MIC) values for cephalothin-resistant Enterobacteriaceae.
In this report we present additional data on the high activity of cefotaxime; we also compare this antibiotic with other cephalosporins with regard to their susceptibility to beta-lactamases and its relationship to their MIC values.
MATERIALS AND (6, 12) . The high intrinsic activity even extends to Pseudomonas aeruginosa, which shows MIC values of about 16 ,ug/ml, a concentration which may be attained in vivo. Haemophilus influenzae, although susceptible to most cephalosporins, shows marked susceptibility to cefotaxime, also in agreement with earlier reports (1, 6). Only S. aureus is more susceptible to cephalothin, with cefazolin and cefamandole being next in order.
The difference between cefamandole and the other three new cephalosporins with regard to the effect of inoculum size, although not statistically significant, seems to reflect the differences in susceptibility to beta-lactamase, as shown in Table 2 .
Rates of hydrolysis of cefotaxime by beta-lactamases have only been published by Fu and Neu (4), who also used the spectrophotometric method. Their results show differences from ours since they could not find any beta-lactamase activity against cefotaxime and cefuroxime, whereas we did find some activity against these two antibiotics, i.e., up to 10% of the activity against cephalothin. Other types of strains used for preparing the cell-free extracts or small differences in techniques may explain these differences. Cefoxitin could not be found to be hydrolyzed in either investigation.
The most intriguing phenomenon is lack of a relationship between MIC values and beta-lactamase susceptibility, which has already been recorded for several new cephalosporins (3, 11) .
Cefamandole is about equally susceptible to most beta-lactamases as is cephalothin, but the MIC values are much lower than those of cefoxitin, which is not hydrolyzed at all. However, a closer look at the data for cefamandole suggests some correlation, i.e., the higher beta-lactamase activity of strains usually corresponding with higher MIC values and vice versa.
For the purpose of choosing from among these new cephalosporins for clinical use, it has yet to be elucidated what consequences accrue from the lack of the usual relationship between MIC values and beta-lactamase susceptibility. Does this mean that the beta-lactamase susceptibility is unimportant as a parameter for clinical usefulness, or does it imply that we should be careful in using the MIC as such a parameter? LITERATURE CITED 
